Release Date: 30/07/14 16:51 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 44.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%